Stocktoria
111, Inc. YI
Nasdaq · XNAS · stock · Retail-Drug Stores and Proprietary Stores · website · IPO 2018-09-12
111, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.8B | $2.0B | $2.1B | $2.0B | $1.9B |
| Gross profit | $723.4M | $829.2M | $849.0M | $840.0M | $621.1M |
| Operating income | -$340,000 | $289,000 | -$49.3M | -$53.8M | -$100.8M |
| Interest expense | — | — | $2.8M | $1.9M | $861,000 |
| Income tax | $2,000 | $13,000 | $35,000 | $0 | $0 |
| Operating cash flow | $17.0M | $36.0M | -$63.0M | -$3.4M | -$108.1M |
| Free cash flow | $16.4M | $34.0M | -$64.4M | -$7.9M | -$117.9M |
| Cash & equivalents | $73.1M | $63.3M | $85.0M | $97.7M | $103.8M |
| Inventory | $142.8M | $190.1M | $199.9M | $217.3M | $175.9M |
| Total assets | $314.6M | $381.9M | $435.1M | $503.7M | $493.6M |
| Total liabilities | $284.0M | $329.8M | $396.2M | $409.7M | $360.5M |
| Shareholders' equity | -$103.2M | -$90.2M | -$83.8M | -$60.1M | -$27.2M |
| EPS (diluted) | $-0.05 | $-0.05 | $-0.33 | $-0.36 | $-0.63 |
Source: SEC EDGAR filings · CIK 0001738906 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.